244 related articles for article (PubMed ID: 28012760)
1. Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging.
Gleason DF; Mellinger GT;
J Urol; 2017 Feb; 197(2S):S134-S139. PubMed ID: 28012760
[No Abstract] [Full Text] [Related]
2. Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
Zincke H
Semin Urol; 1990 Aug; 8(3):175-83. PubMed ID: 2399386
[No Abstract] [Full Text] [Related]
3. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.
Gleason DF; Mellinger GT
J Urol; 1974 Jan; 111(1):58-64. PubMed ID: 4813554
[No Abstract] [Full Text] [Related]
4. Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term followup.
Myers RP; Larson-Keller JJ; Bergstralh EJ; Zincke H; Oesterling JE; Lieber MM
J Urol; 1992 Mar; 147(3 Pt 2):910-5. PubMed ID: 1538495
[TBL] [Abstract][Full Text] [Related]
5. Latent carcinoma of the prostate--why the controversy?
Correa RJ; Anderson RG; Gibbons RP; Mason JT
J Urol; 1974 May; 111(5):644-6. PubMed ID: 4823973
[No Abstract] [Full Text] [Related]
6. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
Zincke H; Utz DC; Taylor WF
J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long-term results of a prospective randomized study.
Zagars GK; Johnson DE; von Eschenbach AC; Hussey DH
Int J Radiat Oncol Biol Phys; 1988 Jun; 14(6):1085-91. PubMed ID: 3133327
[TBL] [Abstract][Full Text] [Related]
8. Lymphatic Vascularization in Prostate Adenocarcinoma: Correlation with Tumor Grade, Androgen Withdrawal and Prognosis.
Ambrosio MR; Rocca BJ; Barone A; Ginori A; Crivelli F; Pirtoli L; Del Vecchio MT
Anticancer Res; 2015 Oct; 35(10):5595-600. PubMed ID: 26408731
[TBL] [Abstract][Full Text] [Related]
9. Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate.
Seay TM; Blute MC; Zincke H
Urology; 1997 Dec; 50(6):833-7. PubMed ID: 9426709
[No Abstract] [Full Text] [Related]
10. Prostate cancer in men less than 45 years old: influence of stage, grade and therapy.
Benson MC; Kaplan SA; Olsson CA
J Urol; 1987 May; 137(5):888-90. PubMed ID: 3573183
[TBL] [Abstract][Full Text] [Related]
11. Relapse on endocrine treatment in patients with stage D2 prostate cancer. Does second-line hormonal therapy affect survival?
Matzkin H; Rangel MC; Soloway MS
Urology; 1993 Feb; 41(2):144-8. PubMed ID: 8497986
[TBL] [Abstract][Full Text] [Related]
12. Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate.
Zincke H; Utz DC; Thulé PM; Taylor WF
Urology; 1987 Oct; 30(4):307-15. PubMed ID: 3660520
[TBL] [Abstract][Full Text] [Related]
13. Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology.
Vesalainen S; Lipponen P; Nordling S; Talja M; Syrjänen K
Anticancer Res; 1995; 15(2):569-73. PubMed ID: 7763039
[TBL] [Abstract][Full Text] [Related]
14. [Present status and questions on early prostatic cancer (stage A, B)].
Oishi K; Arai Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
[TBL] [Abstract][Full Text] [Related]
15. [Retrospective clinical evaluation of prognosis factors in stage D2 prostatic cancer treated with endocrine therapy].
Kudo K; Nagata M; Hayashi N; Imamura H; Kimura M; Mimura H; Matsuyama K; Shishido S; Chino I
Hinyokika Kiyo; 1991 Feb; 37(2):129-34. PubMed ID: 1710871
[TBL] [Abstract][Full Text] [Related]
16. Differential Risk of Castration Resistance After Initial Radical Prostatectomy or Radiotherapy for Prostate Cancer.
Obata H; Shiota M; Akitake N; Takeuchi A; Kashiwagi E; Dejima T; Kiyoshima K; Inokuchi J; Tatsugami K; Eto M
Anticancer Res; 2017 Oct; 37(10):5631-5637. PubMed ID: 28982880
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis of the patients with prostate cancer clinically confined within the pelvis].
Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T
Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609
[TBL] [Abstract][Full Text] [Related]
18. Presidential Address of the 24th Annual Meeting of the American Society of Therapeutic Radiologists: carcinoma of the prostate, a vexing biological and clinical enigma.
Perez CA
Int J Radiat Oncol Biol Phys; 1983 Oct; 9(10):1427-38. PubMed ID: 6629886
[No Abstract] [Full Text] [Related]
19. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
Blackard CE; Byar DP; Jordan WP
Urology; 1973 Jun; 1(6):553-60. PubMed ID: 4588820
[No Abstract] [Full Text] [Related]
20. Seminal Vesicle Invasion by Adenocarcinoma of the Prostate.
Humphrey PA
J Urol; 2015 Dec; 194(6):1757-8. PubMed ID: 26386279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
